Eisai Co., Ltd. (TYO:4523)
4,050.00
+70.00 (1.76%)
May 27, 2026, 11:30 AM JST
Eisai Revenue
In the fiscal year ending March 31, 2026, Eisai had annual revenue of 825.38B JPY with 4.56% growth. Eisai had revenue of 205.43B in the quarter ending March 31, 2026, with 9.13% growth.
Revenue
825.38B
Revenue Growth
+4.56%
P/S Ratio
1.36
Revenue / Employee
75.60M
Employees
10,917
Market Cap
1.12T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 825.38B | 35.98B | 4.56% |
| Mar 31, 2025 | 789.40B | 47.65B | 6.42% |
| Mar 31, 2024 | 741.75B | -2.65B | -0.36% |
| Mar 31, 2023 | 744.40B | -11.82B | -1.56% |
| Mar 31, 2022 | 756.23B | 110.28B | 17.07% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.51T |
| Toho Holdings | 1.55T |
| Shionogi & | 499.68B |
| Sumitomo Pharma | 453.29B |
| Towa Pharmaceutical | 273.71B |
| Sawai Group Holdings | 201.68B |
| Tsumura & Co. | 192.62B |
| Nippon Shinyaku | 170.77B |
Eisai News
- 1 day ago - BioArctic's partner Eisai presents sales simulation of potential future sales of Leqembi® at its Investor Relations Day - PRNewsWire
- 1 day ago - Eisai Transcript: Investor Day 2026 - Transcripts
- 1 day ago - Eisai Slides: FY 2026 - Filings
- 8 days ago - Full Year 2026 Eisai Co Ltd Earnings Presentation Transcript - GuruFocus
- 11 days ago - Eisai Earnings Call Transcript: Q4 2026 - Transcripts
- 11 days ago - Eisai Quarterly report: Q4 2026 - Filings
- 11 days ago - Eisai Slides: Q4 2026 - Filings
- 11 days ago - Eisai projects Leqembi® revenue to total JPY 143.5 billion for fiscal year 2026 (April 2026 - March 2027) - PRNewsWire